SC Engineering Co (023960) Fair Value & Analysis
Industrials · KR · Market cap 36.9B KRW
Fair value as of: Jul 6, 2026
From 3 valuation models · updated today
Fair value updated Jul 6, 2026 — revised from 5,587 KRW to 151.49 KRW (−97.3%) since Jun 24, 2026. Share price +8.8% over the past month.
Price vs Fair Value (12 months)
12‑month range 905.00 KRW – 1,891 KRW · fair‑value band 136.83 KRW – 174.30 KRW · the 1,024 KRW price screens above the 151.49 KRW fair value. As of Jul 6, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SC Engineering Co (023960) currently trades at 1,024 KRW, while our model-based Fair Value estimate is 151.49 KRW — implying the stock looks roughly 85.2% overvalued today. We read business quality at 30/100 (below-average quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).
Over the trailing twelve months, SC Engineering Co generated revenue of 156B KRW at a net margin of -4.1%. Revenue declined 46.6% year over year. It earns a return on equity of -14.3%. Net debt stands at 4.2B KRW. Fundamentals as of Jul 6, 2026
Our scenario range runs from 136.83 KRW (bear case) to 174.30 KRW (bull case); at 1,024 KRW, the current price sits above that range. The share trades about 48% below its 52-week high and 15% above its 52-week low, currently below its 200-day average. For context, the median of 10 Industrials peers we cover trades at -22% fair-value upside — at -85%, 023960 screens richer than that median.
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.
About the company
SC Engineering Co., Ltd., together with its subsidiaries, operates as an engineering company in South Korea and internationally. The company engages in the manufacturing, selling, importing, and exporting of biological products and medical devices using cell culture. It is also involved in the engineering, procurement, and construction of material, industry, and energy platforms, as well as industrial facilities; supplying of cosmetic and health food products; and provision of storage services for hematopoietic stem cells and medical equipment. The company was formerly known as Sewoncellontech Co., Ltd. and changed its name to SC Engineering Co., Ltd. in 2006. SC Engineering Co., Ltd. was founded in 1971 and is headquartered in Seoul, South Korea.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SC Engineering Co reported revenue of 172B KRW in FY2025 versus 75.7B KRW in FY2021, a compound +22.8%/yr. Reported net income was −4.8B KRW in FY2025.
Is 023960 fairly valued? → Check now
Similar stocks
10 more Engineering & Construction stocks, each showing price versus our Fair Value estimate (as of Jul 6, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Larsen & Toubro Limited LTOD | $0.4415 | $0.5700 | +29% |
| Samsung C&T Corporation 028260 | 407,500 KRW | 236,704 KRW | -42% |
| China State Construction Engineering Corporation 601668 | ¥4.72 | ¥16.90 | +258% |
| TopBuild Corp BLD | 7,547 MXN | 4,541 MXN | -40% |
| Hyundai Engineering & Construction Co 000720 | 130,300 KRW | 55,602 KRW | -57% |
| United Integrated Services Co 2404 | 1,195 TWD | 1,681 TWD | +41% |
| Samsung E&A Co 028050 | 48,350 KRW | 37,697 KRW | -22% |
| Daewoo Engineering & Construction Co 047040 | 21,800 KRW | 16,217 KRW | -26% |
| L&K Engineering Co 6139 | 791.00 TWD | 782.96 TWD | -1% |
| Rail Vikas Nigam Limited RVNL | ₹235.61 | ₹14.53 | -94% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is SC Engineering Co (023960) undervalued?
What is the fair value of 023960?
What is the quality score of 023960?
What is the revenue of SC Engineering Co (023960)?
What is the net profit margin of 023960?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.